Linked Data API

Show Search Form

Search Results

1036912
star this property registered interest false more like this
star this property date less than 2019-01-07more like thismore than 2019-01-07
star this property answering body
Treasury more like this
star this property answering dept id 14 more like this
unstar this property answering dept short name Treasury more like this
unstar this property answering dept sort name Treasury more like this
star this property hansard heading Brexit more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what is their assessment of the current financial cost to the UK of delivering Brexit. more like this
star this property tabling member printed
Lord Roberts of Llandudno more like this
star this property uin HL12554 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>The precise scale and nature of any benefits and costs to the UK, from the UK’s departure from the European Union, will depend on the UK’s future relationship with the EU.</p><p> </p><p>I am, however, able to provide some detail on how much the government has spent to-date to prepare for all scenarios. In total over £4.2bn has been allocated by the government to departments and devolved administrations to prepare for EU exit since 2015.</p><p> </p><p>This includes allocations of £400m at Autumn Budget 2016 and over £250m from the Reserve in 2017/18. Moreover, Autumn Budget 2017 committed an additional £3bn over 2018/19 and 2019/20. In addition, at Budget 2018, the Chancellor made available an additional £500m for 19/20.</p><p><strong> </strong></p> more like this
star this property answering member printed Lord Bates more like this
unstar this property question first answered
less than 2019-01-21T15:49:09.633Zmore like thismore than 2019-01-21T15:49:09.633Z
star this property answering member
1091
unstar this property label Biography information for Lord Bates more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno remove filter
1036910
star this property registered interest false more like this
star this property date less than 2019-01-07more like thismore than 2019-01-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to ensure that the supply of medicines into the UK will not be disrupted as a result of Brexit; and what is the cost of any such steps. more like this
star this property tabling member printed
Lord Roberts of Llandudno more like this
star this property uin HL12552 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>The Government has now agreed the Withdrawal Agreement with the European Commission, which includes an implementation period that will run from March 2019 until December 2020. During this time, the supply of medicines will remain unchanged. As a responsible Government, however, we continue to prepare proportionately for all scenarios, including ‘no deal’.</p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the United Kingdom that come from, or via, the European Union or European Economic Area (EEA) asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit. In the light of this engagement, the Department is currently considering how best it may support those companies taking part in the contingency planning.</p><p>Additionally, a tender process to procure additional warehouse space for stockpiled medicines, including ambient, refrigerated and controlled drug storage, was undertaken in October 2018. Contract agreements for storage have recently been signed or are imminent. This is expected to cost the Government in the low tens of millions of pounds.</p><p>Whilst the six-week stockpiling activity remains a critical part of our contingency plans, this has been supplemented with additional actions. The Government recognises the importance of medicines and is working to ensure that there is sufficient roll-on, roll-off freight capacity to enable these vital products to continue to move freely in to the UK from 29 March in a ‘no deal’ scenario. The Department is working closely with the Department for Transport to ensure all medicines and medical products are prioritised on these alternative routes to ensure that the flow of all these products will continue unimpeded after 29 March 2019.</p><p>On 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA, and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone. Since then we have been working closely with those companies to better understand their supply chains and the potential for rerouting in a ‘no deal’ scenario.</p><p> </p>
star this property answering member printed Baroness Manzoor more like this
unstar this property question first answered
less than 2019-01-21T16:25:51.64Zmore like thismore than 2019-01-21T16:25:51.64Z
star this property answering member
4289
unstar this property label Biography information for Baroness Manzoor more like this
unstar this property tabling member
3691
unstar this property label Biography information for Lord Roberts of Llandudno remove filter